Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
05/2012
05/16/2012CN102459251A 作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物 Compound bicyclic heteroaryl moiety having two fused leukotriene a4 hydrolase as modulators of
05/16/2012CN102459249A 作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxazepine cycloheptatriene and their use and manufacturing method
05/16/2012CN102453043A Racemization method of dexamisole base
05/15/2012US8178555 Apoptosis signal-regulating kinase 1 inhibitors
05/15/2012US8178524 Noribogaine in the treatment of pain and drug addiction
05/15/2012CA2518620C 2,4,6-phenyl substituted cyclic ketoenols
05/15/2012CA2470863C Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
05/10/2012WO2012059041A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors
05/10/2012US20120116077 [1,2,4]thiadiazin-3-yl acetic acid compound[[s]] and methods of making the acetic acid compound
05/10/2012US20120114633 Inhibitors Of Bacterial Type III Secretion System
05/10/2012US20120114601 New isothiazoloquinolones and related compounds as anti-infective agents
05/10/2012CA2829117A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors
05/09/2012EP2450358A1 Fused, tricyclic sulfonamide inhibitors of gamma secretase
05/09/2012EP2448946A1 2-carboxamide cycloamino ureas useful as pi3k inhibitors
05/09/2012EP2448938A1 Pyrimidinones as pi3k inhibitors
05/09/2012CN102448969A Inhibitors of C-MET protein kinase
05/09/2012CN102448968A Substituted pyrazole inhibitors of c-met protein kinase
05/09/2012CN102448946A Materials for organic electroluminescent devices
05/09/2012CN102442970A Novel compounds as cannabinoid receptor ligands and uses thereof
05/09/2012CN101448843B Imidazolothiazole compounds for the treatment of disease
05/08/2012US8173649 Glucokinase activator
05/08/2012US8173645 Glucokinase activators
05/08/2012CA2507027C Isoquinoline compounds and medicinal use thereof
05/03/2012US20120108618 Thia-triaza-indacenes
05/03/2012US20120108591 Alkylsulfinyl-substituted thiazolide compounds
05/03/2012US20120108576 Thiazole compounds and methods of use
05/03/2012US20120108567 Thiazolyl-Dihydro-Indazoles
05/03/2012US20120107273 New piperazine compound and use thereof as a hcv polymerase inhibitor
05/02/2012EP1415992B1 Diamine derivatives
05/02/2012CN102438992A Method of inducing cleavage of amyloid precursor protein to form a novel fragment
04/2012
04/26/2012WO2012054367A1 Rho kinase inhibitors
04/26/2012WO2012052668A1 Novel benzothiophene derivatives with tnap-inhibiting activity
04/26/2012US20120101243 Substituted benzazoloporphyrazines for polymerization and surface attachment and articles formed therefrom
04/26/2012US20120101082 Vasopressin v1a antagonists
04/25/2012EP2444397A1 Heteroaryl-ureas and their use as glucokinase activators
04/25/2012EP2444087A1 Pharmaceutical composition having improved solubility
04/25/2012EP2443121A2 Gamma secretase modulators
04/25/2012EP2247586B1 2-aza-bicyclo[2.2.1]heptane derivatives
04/25/2012EP1482933B1 Potent, simplified derivatives of immunosuppressive agents
04/25/2012CN102424689A 甲磺酸左旋尤利沙星晶体及其制备方法和用途 L You Lisha mesylate Star crystal and preparation method and uses
04/25/2012CN102424688A 甲磺酸左旋尤利沙星晶体及其制备方法和用途 L You Lisha mesylate Star crystal and preparation method and uses
04/24/2012US8163901 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
04/24/2012US8163770 Benzoxathiin derivative
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/19/2012US20120095219 Process for preparing brinzolamide
04/19/2012US20120094996 Imidazo [2, 1-B] [1, 3, 4] Thiadiazole Derivatives
04/19/2012US20120094984 Fused aminodihydrothiazine derivatives
04/19/2012US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression
04/19/2012US20120094972 Heterocyclic compounds and their uses
04/19/2012CA2814688A1 Heteroaryls and uses thereof
04/18/2012EP2440533A1 Guanine riboswitch binding compounds and their use as antibiotics
04/18/2012EP2440058A1 Fused heterocyclic compounds and their uses
04/18/2012CN102417515A 噻唑(嗪)烷酮并氮杂糖衍生物及合成方法和其在药物制剂中的应用 Thiazole (triazine) and the aza sugar oxazolidinone derivatives and their use in the synthesis methods and pharmaceutical formulations
04/18/2012CN101768172B 用于抗感染的普卢利沙星的光学活性化合物和制备方法 For anti-infective prulifloxacin optically active compounds and preparation methods
04/17/2012US8158620 Fused aminodihydrothiazine derivatives
04/17/2012CA2582447C Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
04/17/2012CA2491680C Inhibitors of ftsz and uses thereof
04/12/2012US20120088771 Tissue-nonspecific alkaline phosphatase (tnap): a therapeutic target for arterial calcification
04/12/2012US20120088766 Fused heterocyclic compounds and their uses
04/12/2012US20120088754 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
04/11/2012EP2439205A1 Carboxamide compounds and their use as calpain inhibitors
04/11/2012EP1948667B1 Thiazolo[4,5-c]pyridine derivatives as mglu5 receptor antagonists
04/11/2012CN102414192A 制备布林唑胺的方法 Preparation methods brinzolamide
04/10/2012US8153649 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes
04/10/2012US8153647 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
04/10/2012US8153626 Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators
04/10/2012US8153619 Diazonamide analogs
04/05/2012WO2012041789A1 Herbicidal benzoxazinones
04/05/2012WO2011146918A3 Macrocyclic compounds and methods of treatment
04/04/2012EP2436687A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
04/04/2012EP2435445A1 Inhibitors of c-met protein kinase
04/04/2012EP2435444A1 Substituted pyrazole inhibitors of c-met protein kinase
04/04/2012EP2435443A1 Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
04/04/2012EP2435438A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
04/04/2012EP2435436A1 Pyrimidine inhibitors of kinase activity
04/04/2012EP2435435A1 Pyrimidine inhibitors of kinase activity
04/04/2012EP1960343B1 Indene derivatives, their preparation and use as medicaments
04/04/2012EP1615878B1 Compounds, compositions and methods of treatment for heart failure
04/03/2012US8148540 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
04/03/2012US8148529 Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof
04/03/2012US8148397 5-HT7 receptor antagonists
04/03/2012US8148396 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
03/2012
03/29/2012WO2011060877A3 Materials for organic light emitting devices
03/29/2012US20120077799 Heterocyclic compound and use thereof
03/28/2012EP2432779A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
03/28/2012EP2432776A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
03/28/2012EP2432318A1 Bimacrocyclic hcv ns3 protease inhibitors
03/28/2012CN102395592A Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
03/28/2012CN102395588A Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
03/28/2012CN102395585A Heteroaryls and their use as pi3k inhibitors
03/28/2012CN102391183A C-19 modified geldanamycin(GDM) derivatives and preparation method thereof
03/28/2012CN102391107A Method for preparing gallic acid quinolone drug salt and preparation method thereof
03/28/2012CN101218237B Oxime derivative and preparations thereof
03/27/2012US8143414 Hepatitis C virus inhibitors
03/27/2012US8143304 (3-amino-1,2,3,4-tetrahydro-9 H-carbazol-9-yl)-acetic acid derivatives
03/27/2012US8143291 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
03/27/2012US8143271 Compounds and methods for kinase modulation, and indications therefor
03/27/2012US8143261 Thiazolo (4,5-D) pyrimidine compounds
03/22/2012WO2012037259A1 Novel inhibitors of hepatitis c virus replication
03/22/2012WO2012036233A1 Condensed heterocyclic derivative having melanine-concentrating hormone receptor antagonistic activity
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 152